{"id":4934,"date":"2020-08-28T10:46:00","date_gmt":"2020-08-28T09:46:00","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=4934"},"modified":"2021-10-11T16:27:38","modified_gmt":"2021-10-11T15:27:38","slug":"28-august-2020-recommendations-beam-alliance-and-global-partners-call-for-urgent-action-on-new-reimbursement-models-for-life-saving-antibiotics","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/bilans-rapports-et-recommandations\/28-august-2020-recommendations-beam-alliance-and-global-partners-call-for-urgent-action-on-new-reimbursement-models-for-life-saving-antibiotics\/","title":{"rendered":"28 August 2020 \u2013 Recommendations &#8211; BEAM Alliance and global partners call for urgent action on new reimbursement models for life-saving antibiotics"},"content":{"rendered":"\n<p>The BEAM Alliance, together with high-level partners of the AMR ecosystem, are calling for urgent action on designing and implementing new economic incentive models (\u201cPULL\u201d incentives) for the development and commercialization of AMR products (see attached).<\/p>\n\n\n\n<p>Whilst the COVID-19 crisis is having a devastating effect on global health and an unprecedented impact on the global economy, the AMR community is highly concerned by the pre-pandemic stage of the AMR threat and by the lack of progress made so far on fixing its related market failure.<\/p>\n\n\n\n<p>We, as a community, are calling the EU and Member States to rapidly introduce and implement a relevant legislative framework able to address the problem.<\/p>\n\n\n\n<p>Such a framework is paramount for Europe to build resilience in front of the AMR threat. Co-signatories of the paper attached are willing to take their part in this endeavour.<\/p>\n\n\n\n<ul><li>Access the publication : <a href=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/09\/2020.08.28-Post-AMR-Conference-paper-BEAM-alliance-and-Global-Partners.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">BEAM Alliance and global partners call for urgent action on new reimbursement models for life-saving antibiotic<\/a>s<\/li><\/ul>\n","protected":false},"excerpt":{"rendered":"<p>The BEAM Alliance, together with high-level partners of the AMR ecosystem, are calling for urgent action on designing and implementing new economic incentive models (\u201cPULL\u201d incentives) for the development and commercialization of AMR products (see attached). Whilst the COVID-19 crisis is having a devastating effect on global health and an unprecedented impact on the global [&hellip;]<\/p>\n","protected":false},"author":139,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[37],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>28 August 2020 \u2013 Recommendations - BEAM Alliance and global partners call for urgent action on new reimbursement models for life-saving antibiotics - Interface nationale ANTIBIOR\u00c9SISTANCE<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/bilans-rapports-et-recommandations\/28-august-2020-recommendations-beam-alliance-and-global-partners-call-for-urgent-action-on-new-reimbursement-models-for-life-saving-antibiotics\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"28 August 2020 \u2013 Recommendations - BEAM Alliance and global partners call for urgent action on new reimbursement models for life-saving antibiotics - Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/bilans-rapports-et-recommandations\/28-august-2020-recommendations-beam-alliance-and-global-partners-call-for-urgent-action-on-new-reimbursement-models-for-life-saving-antibiotics\/\" \/>\n<meta property=\"og:site_name\" content=\"Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"article:published_time\" content=\"2020-08-28T09:46:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-10-11T15:27:38+00:00\" \/>\n<meta name=\"author\" content=\"\u00c9milie Noguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9milie Noguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/bilans-rapports-et-recommandations\/28-august-2020-recommendations-beam-alliance-and-global-partners-call-for-urgent-action-on-new-reimbursement-models-for-life-saving-antibiotics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/bilans-rapports-et-recommandations\/28-august-2020-recommendations-beam-alliance-and-global-partners-call-for-urgent-action-on-new-reimbursement-models-for-life-saving-antibiotics\/\"},\"author\":{\"name\":\"\u00c9milie Noguez\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\"},\"headline\":\"28 August 2020 \u2013 Recommendations &#8211; BEAM Alliance and global partners call for urgent action on new reimbursement models for life-saving antibiotics\",\"datePublished\":\"2020-08-28T09:46:00+00:00\",\"dateModified\":\"2021-10-11T15:27:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/bilans-rapports-et-recommandations\/28-august-2020-recommendations-beam-alliance-and-global-partners-call-for-urgent-action-on-new-reimbursement-models-for-life-saving-antibiotics\/\"},\"wordCount\":178,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"articleSection\":[\"Bilans, rapports et recommandations\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/bilans-rapports-et-recommandations\/28-august-2020-recommendations-beam-alliance-and-global-partners-call-for-urgent-action-on-new-reimbursement-models-for-life-saving-antibiotics\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/bilans-rapports-et-recommandations\/28-august-2020-recommendations-beam-alliance-and-global-partners-call-for-urgent-action-on-new-reimbursement-models-for-life-saving-antibiotics\/\",\"name\":\"28 August 2020 \u2013 Recommendations - BEAM Alliance and global partners call for urgent action on new reimbursement models for life-saving antibiotics - Interface nationale ANTIBIOR\u00c9SISTANCE\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\"},\"datePublished\":\"2020-08-28T09:46:00+00:00\",\"dateModified\":\"2021-10-11T15:27:38+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/bilans-rapports-et-recommandations\/28-august-2020-recommendations-beam-alliance-and-global-partners-call-for-urgent-action-on-new-reimbursement-models-for-life-saving-antibiotics\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/bilans-rapports-et-recommandations\/28-august-2020-recommendations-beam-alliance-and-global-partners-call-for-urgent-action-on-new-reimbursement-models-for-life-saving-antibiotics\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/bilans-rapports-et-recommandations\/28-august-2020-recommendations-beam-alliance-and-global-partners-call-for-urgent-action-on-new-reimbursement-models-for-life-saving-antibiotics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infos pratiques &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Bilans, rapports et recommandations\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/bilans-rapports-et-recommandations\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"28 August 2020 \u2013 Recommendations &#8211; BEAM Alliance and global partners call for urgent action on new reimbursement models for life-saving antibiotics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"name\":\"Interface nationale ANTIBIOR\u00c9SISTANCE\",\"description\":\"PPR Antibior\u00e9sistance - Inserm\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\",\"name\":\"\u00c9milie Noguez\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"28 August 2020 \u2013 Recommendations - BEAM Alliance and global partners call for urgent action on new reimbursement models for life-saving antibiotics - Interface nationale ANTIBIOR\u00c9SISTANCE","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/bilans-rapports-et-recommandations\/28-august-2020-recommendations-beam-alliance-and-global-partners-call-for-urgent-action-on-new-reimbursement-models-for-life-saving-antibiotics\/","og_locale":"fr_FR","og_type":"article","og_title":"28 August 2020 \u2013 Recommendations - BEAM Alliance and global partners call for urgent action on new reimbursement models for life-saving antibiotics - Interface nationale ANTIBIOR\u00c9SISTANCE","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/bilans-rapports-et-recommandations\/28-august-2020-recommendations-beam-alliance-and-global-partners-call-for-urgent-action-on-new-reimbursement-models-for-life-saving-antibiotics\/","og_site_name":"Interface nationale ANTIBIOR\u00c9SISTANCE","article_published_time":"2020-08-28T09:46:00+00:00","article_modified_time":"2021-10-11T15:27:38+00:00","author":"\u00c9milie Noguez","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"\u00c9milie Noguez","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/bilans-rapports-et-recommandations\/28-august-2020-recommendations-beam-alliance-and-global-partners-call-for-urgent-action-on-new-reimbursement-models-for-life-saving-antibiotics\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/bilans-rapports-et-recommandations\/28-august-2020-recommendations-beam-alliance-and-global-partners-call-for-urgent-action-on-new-reimbursement-models-for-life-saving-antibiotics\/"},"author":{"name":"\u00c9milie Noguez","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3"},"headline":"28 August 2020 \u2013 Recommendations &#8211; BEAM Alliance and global partners call for urgent action on new reimbursement models for life-saving antibiotics","datePublished":"2020-08-28T09:46:00+00:00","dateModified":"2021-10-11T15:27:38+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/bilans-rapports-et-recommandations\/28-august-2020-recommendations-beam-alliance-and-global-partners-call-for-urgent-action-on-new-reimbursement-models-for-life-saving-antibiotics\/"},"wordCount":178,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"articleSection":["Bilans, rapports et recommandations"],"inLanguage":"fr-FR"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/bilans-rapports-et-recommandations\/28-august-2020-recommendations-beam-alliance-and-global-partners-call-for-urgent-action-on-new-reimbursement-models-for-life-saving-antibiotics\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/bilans-rapports-et-recommandations\/28-august-2020-recommendations-beam-alliance-and-global-partners-call-for-urgent-action-on-new-reimbursement-models-for-life-saving-antibiotics\/","name":"28 August 2020 \u2013 Recommendations - BEAM Alliance and global partners call for urgent action on new reimbursement models for life-saving antibiotics - Interface nationale ANTIBIOR\u00c9SISTANCE","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website"},"datePublished":"2020-08-28T09:46:00+00:00","dateModified":"2021-10-11T15:27:38+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/bilans-rapports-et-recommandations\/28-august-2020-recommendations-beam-alliance-and-global-partners-call-for-urgent-action-on-new-reimbursement-models-for-life-saving-antibiotics\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/bilans-rapports-et-recommandations\/28-august-2020-recommendations-beam-alliance-and-global-partners-call-for-urgent-action-on-new-reimbursement-models-for-life-saving-antibiotics\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/bilans-rapports-et-recommandations\/28-august-2020-recommendations-beam-alliance-and-global-partners-call-for-urgent-action-on-new-reimbursement-models-for-life-saving-antibiotics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"Infos pratiques &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/"},{"@type":"ListItem","position":3,"name":"Bilans, rapports et recommandations","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/bilans-rapports-et-recommandations\/"},{"@type":"ListItem","position":4,"name":"28 August 2020 \u2013 Recommendations &#8211; BEAM Alliance and global partners call for urgent action on new reimbursement models for life-saving antibiotics"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","name":"Interface nationale ANTIBIOR\u00c9SISTANCE","description":"PPR Antibior\u00e9sistance - Inserm","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3","name":"\u00c9milie Noguez"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-22 09:30:36","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/4934"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/users\/139"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/comments?post=4934"}],"version-history":[{"count":3,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/4934\/revisions"}],"predecessor-version":[{"id":18037,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/4934\/revisions\/18037"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media?parent=4934"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/categories?post=4934"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/tags?post=4934"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}